Skip To Main Content
Joan Sesing Lenz on Muck Rack

Joan Sesing Lenz

As seen in: BioRxiv, medRxiv
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Joan Sesing

Contact Joan Sesing, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Cell-free RNA Liquid Biopsy to Monitor Hematopoietic Stem Cell Transplantation

|
By Conor J Loy, Matthew P. Cheng, Joan Sesing Lenz, Isabel Gonzalez-Bocco
| medRxiv
C.J.L and I.D.V are inventors on submitted patents pertaining to cell-free nucleic acids (US patent applications 63/237,367 and 63/429,733). I.D.V. is a member of the Scientific Advisory Board of Karius Inc., Kanvas Biosciences and GenDX. I.D.V. is listed as an inventor on submitted patents pertaining to cell-free nucleic acids (US patent applications 63/237,367, 63/056,249, 63/015,095, 16/500,929, 41614P-10551-01-US) and receives consulting fees from Eurofins Viracor.
Open in Who Shared Issue with article?

Cell-free DNA Tissues-of-Origin Profiling to Predict Graft versus Host Disease and Detect Infection after Hematopoietic Cell Transplantation

|
By Alexandre Pellan Cheng, Matthew Pellan Cheng, Joan Sesing Lenz, Kaiwen W. Chen
| BioRxiv
ABSTRACT Allogeneic hematopoietic cell transplantation (HCT) provides effective treatment for hematologic malignancies and immune disorders. Monitoring for immune complications and infection is a critical component of post-HCT therapy, however, current diagnostic options are limited.
Open in Who Shared Issue with article?
See all 2 articles